Article
Regeneron Stock Soars On Successful Trial News
Rating:
0.0
Views:
88
Likes:
1
Library:
1
Studies "support aflibercept 8 mg as a potential new standard-of-care," Regeneron Pharmaceuticals said. Regeneron stock leapt in huge volume.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value